Format

Send to

Choose Destination
Trends Pharmacol Sci. 2000 Mar;21(3):109-17.

Galanin receptor subtypes.

Author information

1
Synaptic Pharmaceutical Corporation, 215 College Road, Paramus, NJ 07652, USA. tabranchek@synapticcorp.com

Abstract

The neuropeptide galanin, which is widely expressed in brain and peripheral tissues, exerts a broad range of physiological effects. Pharmacological studies using peptide analogues have led to speculation about multiple galanin receptor subtypes. Since 1994, a total of three G-protein-coupled receptor (GPCR) subtypes for galanin have been cloned (GAL1, gal2 and gal3). Potent, selective antagonists are yet to be found for any of the cloned receptors. Major challenges in this field include linking the receptor clones with each of the known physiological actions of galanin and evaluating the evidence for additional galanin receptor subtypes.

PMID:
10689365
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center